Suppression of allergen-specific B lymphocytes by chimeric protein-engineered antibodies

Immunobiology

Volumn 219, Issue 1, 2014, Pages 45-52

  Kerekov, Nikola ^a   Michova, Antoaneta ^b   Muhtarova, Maryia ^b   Nikolov, Georgi ^b   Mihaylova, Nikolina ^a   Petrunov, Bogdan ^b   Nikolova, Maria ^b   Tchorbanov, Andrey ^a  

^a INSTITUTE OF MICROBIOLOGY   (Bulgaria)

^b NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

Author keywords

Allergen specific B lymphocytes; Allergy; CR1; HDM; Protein chimera

Indexed keywords

ALLERGEN; B LYMPHOCYTE RECEPTOR; COMPLEMENT COMPONENT C3B RECEPTOR; DER P 1; DER P 1 P52 71; IMMUNOGLOBULIN E ANTIBODY; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ADULT; ALLERGIC RHINITIS; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; ASTHMA; B LYMPHOCYTE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS LINKING; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ENGINEERING; T LYMPHOCYTE;

1-ETHYL-3(3′-DIMETHYLAMINOPROPYL; 5-BROMO-4-CHLORO-3-INDOLYL PHOSPHATE; ALLERGEN-SPECIFIC B LYMPHOCYTES; ALLERGY; B CELL RECEPTOR; BCIP; BCR; COMPLEMENT RECEPTOR 1; CR1; DERMATOPHAGOIDES PTERONYSSINUS; DOUBLE STRANDED DNA; DPT; DSDNA; EDC; ELISA; ELISPOT; ENZYME-LINKED IMMUNO-SORBENT ANALYSIS; ENZYME-LINKED IMMUNOSORBENT SPOT; FACS; FCS; FETAL CALF SERUM; FITC; FLUORESCEIN ISOTHIOCYANATE; FLUORESCENCE-ACTIVATED CELL SORTING; HDM; HOUSE DUST MITE; IFN-Γ; INTERFERON GAMMA; MAB; MONOCLONAL ANTIBODY; NBT; NITRO BLUE TETRAZOLIUM; PBMCS; PE; PERIPHERAL BLOOD MONONUCLEAR CELLS; PHICOERYTHRIN; PROTEIN CHIMERA; SCFV; SCID; SD; SDS-PAGE; SEVERE COMBINED IMMUNODEFICIENCY; SINGLE CHAIN FV; SIT; SLE; SODIUM DODECYL SULFATE-POLYACRYLAMIDE GEL ELECTROPHORESIS; SPECIFIC IMMUNOTHERAPY; STANDARD DEVIATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ALLERGENS; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, DERMATOPHAGOIDES; APOPTOSIS; ARTHROPOD PROTEINS; B-LYMPHOCYTES; BLOTTING, WESTERN; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; DERMATOPHAGOIDES PTERONYSSINUS; FEMALE; FLOW CYTOMETRY; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; LEUKOCYTES, MONONUCLEAR; MALE; MOLECULAR SEQUENCE DATA; PROTEIN ENGINEERING; RECOMBINANT FUSION PROTEINS; YOUNG ADULT;

EID: 84888039035     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2013.07.009     Document Type: Article

References (39)

1. Baiu D.C., Prechl J., Tchorbanov A., Molina H.D., Erdei A., Sulica A., Capel P.J., Hazenbos W.L. Modulation of the humoral response by antibody-mediated antigen targeting to complement receptors and Fc receptors. J. Immunol. 1999, 162:3125-3130.
2. Ball T., Fuchs T., Sperr W.R., Valent P., Vangelista L., Kraft D., Valenta R. B cell epitopes of the major timothy grass pollen allergen, Phl p1, revealed by gene fragmentation as candidates for immunotherapy. FASEB J. 1999, 13:1277-1290.
3. Bauminger S., Wilchek M. The use of carbodiimides in the preparation of immunizing conjugates. Methods Enzymol. 1980, 70:151-159.
4. Charbonnier A.S., Hammad H., Gosset P., Stewart G.A., Alkan S., Tonnel A.B., Pestel J. Der p 1-pulsed myeloid and plasmacytoid dendritic cells from house dust mite-sensitized allergic patients dysregulate the T cell response. J. Leukoc. Biol. 2003, 73:91-99.
5. Champelovier P., Valiron O., Michèle J., Dominique L., Scigncurin D. Selection and characterization of an erythroeosinophilic subclone (LAMA-87) and an eosinophilic subclone (LAMA-88) from the multipotential cell line LAMA-84. Leuk. Res. 2004, 18:903-918.
6. Doull I.J., Bright J., Yogeswaran P., Howarth P.H. House-dust mite allergen Der p 1: amount or concentration?. Allergy 1997, 52:220-223.
7. Dreborg S., Akerblom E. Immunotherapy with monomethoxypolyethylene glycol modified allergens. Crit. Rev. Ther. Drug Carrier Syst. 1990, 6:315-365.
8. Duez C., Kips J., Pestel J., Tournoy K., Tonnel A.B., Pauwels R. House dust mite-induced airway changes in hu-SCID mice. Am. J. Respir. Crit. Care Med. 2000, 161:200-206.
9. Duez C., Gras-Masse H., Hammad H., Akoum H., Didierlaurent A., Andre C., Tonnel A.B., Pestel J. Modulation of the allergen-induced human IgE response in Hu-SCID mice: inhibitory effect of human recombinant IFN-gamma and allergen-derived lipopeptide. Eur. Cytokine Netw. 2001, 12:453-461.
10. Duez C., Tsicopoulos A., Janin A., Tillie-Leblond I., Thyphronitis G., Marquillies P., Hamid Q., Wallaert B., Tonnel A.B., Pestel J. An in vivo model of allergic inflammation: pulmonary human cell infiltrate in allergen-challenged allergic Hu-SCID mice. Eur. J. Immunol. 1996, 26:1088-1093.
11. Ewan P. Allergen immunotherapy. Curr. Opin. Immunol. 1990, 1:672-678.
12. Gaffin J., Phipatanakul W. The role of indoor allergens in the development of asthma. Curr. Opin. Allergy Clin. Immunol. 2009, 9:128-135.
13. Gesheva V., Szekeres Z., Mihaylova N., Dimitrova I., Nikolova M., Erdei A., Prechl J., Tchorbanov A. Generation of gene-engineered chimeric DNA molecules for specific therapy of autoimmune diseases. Hum. Gene Therapy Methods 2012, 23:357-365.
14. Greene W., Thomas W. IgE binding structures of the major house dust mite allergen Der p I. Mol. Immunol. 1992, 29:257-262.
15. Gregory L., Lloyd C. Orchestrating house dust mite-associated allergy in the lung. Trends Immunol. 2011, 32:402-411.
16. Hales B., Martin A., Pearce L., Laing I., Hayden C., Goldblatt J., Le Souef P., Thomas W. IgE and IgG anti-house dust mite specificities in allergic disease. J. Allergy Clin. Immunol. 2006, 118:361-367.
17. Ivanovska N., Tchorbanov A., Prechl J., Maximova V., Voynova E., Vassilev T.L. Immunization with a DNA chimeric molecule encoding a hemagglutinin peptide and a scFv CD21-specific antibody fragment induces long-lasting IgM and CTL responses to influenza virus. Vaccine 2006, 24:1830-1837.
18. Jeannin P., Didierlaurent A., Gras-Masse H., Elass A.A., Delneste Y., Cardot E., Joseph M., Tartar A., Vergoten G., Pestel J. Specific histamine release capacity of peptides selected from the modelized Der p I protein, a major allergen of Dermatophagoides pteronyssinus. Mol. Immunol. 1992, 29:739-749.
19. Jozsi M., Prechl J., Bajtay Z., Erdei A. Complement receptor type 1 (CD35) mediates inhibitory signals in human B lymphocytes. J. Immunol. 2002, 168:2782-2788.
20. Kalsheker N.A., Deam S., Chambers L., Sreedharan S., Brocklehurst K., Lomas D.A. The house dust mite allergen Der p1 catalytically inactivates a1-antitrypsin by specific reactive centre loop cleavage: a mechanism that promotes airway inflammation and asthma. Biochem. Biophys. Res. Commun. 1996, 221:59-61.
21. Keles S., Karakoc-Aydiner E., Ozen A., Gul Izgi A., Tevetoglu A., Akkoc T., Bahceciler N., Barlan I. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes. J. Allergy Clin. Immunol. 2011, 128:808-815.
22. Kerekov N., Mihaylova N., Prechl J., Tchorbanov A. Humanized SCID mice models of SLE. Curr. Pharm. Des. 2011, 17:1261-1266.
23. Kerekov N., Mihaylova N., Grozdev I., Todorov T., Nikolova M., Baleva M., Nikolova M., Prechl J., Erdei A., Tchorbanov A. Elimination of autoreactive B cells in humanized SCID mouse model of SLE. Eur. J. Immunol. 2011, 41:3301-3311.
24. King-Konert C., Stocks S., Weinsberg F. First clinical trials of a new heteropolymer technology agent in normal healthy volunteers and patients with systemic lupus erythematosus: safety and proof of principle of the antigen-heteropolymer ETI-104. Ann. Rheum. Dis. 2004, 63:1104-1112.
25. Lu Y.M., Cao L.F., Li C., Li Y.Q., Chen W., Zhang W.M. The effect of specific immunotherapy on natural killer T cells in peripheral blood of house dust mite-sensitized children with asthma. Clin. Develop. Immunol. 2012, 10.1155/2012/148262.
26. Mihaylova N., Voynova E., Tchorbanov A., Nikolova M., Todorov T., Srebreva L., Taskov H., Vassilev T. Selective silencing of disease-associated B-lymphocytes by chimeric molecules targeting their inhibitory receptors. Int. Immunol. 2007, 20:165-175.
27. Mihaylova N., Voynova E., Tchorbanov A., Dolashka-Angelova P., Bayry J., Devreese B., Kaveri S., Vassilev T. Simultaneous engagement of FcgammaIIb and CD22 inhibitory receptors silences targeted B cells and suppresses autoimmune disease activity. Mol. Immunol. 2009, 47:123-130.
28. Pestel J., Jeannin P., Delneste Y., Dessaint J.P., Cesbron J.Y., Capron A., Tsicopoulos A., Tonnel A.B. Human IgE in SCID mice reconstituted with peripheral blood mononuclear cells from Dermatophagoides pteronyssinus-sensitive patients. J. Immunol. 1994, 153:3804-3810.
29. Petrunov B., Nikolov G., Konstantinova D., Antonova T. Preparation and characterization of chemically modified allergen/allergoid/from D. pteronyssinus. GMEI/Moscow/ 1996, 6:61-65.
30. Prechl J., Tchorbanov A., Horvath A., Baiu D.C., Hazenbos W., Rajnavolgyi E., Kurucz I., Capel P.J., Erdei A. Targeting of influenza epitopes to murine CR1/CR2 using single-chain antibodies. Immunopharmacology 1999, 42:159-165.
31. Putterman C., Deocharan B., Diamond B. Molecular analysis of the autoantibody response in peptide-induced autoimmunity. J. Immunol. 2000, 164:2542-2549.
32. Taketomi E.A., Silva D.A., Sopelete M.C., Gervásio A.M., Alves R., Sung S.J. Differential IgE reactivity to Der p 1 and Der p 2 allergens of Dermatophagoides pteronyssinus in mite-sensitized patients. J. Investig. Allergol. Clin. Immunol. 2006, 16:104-109.
33. Tchorbanov A.I., Voynova E., Mihaylova N., Todorov T., Nikolova M., Yomtova V., Chiang B.L., Vassilev T. Selective silencing of DNA-specific B lymphocytes delays lupus activity in MRL/lpr mice. Eur. J. Immunol. 2007, 37:3587-3596.
34. Tsai Y.G., Yang K., Niu D.M., Chien J.W., Lin C.Y. TLR2 agonists enhance CD8+Foxp3+ regulatory T cells and suppress Th2 immune responses during allergen immunotherapy. J. Immunol. 2010, 184:7229-7237.
35. Voynova E., Tchorbanov A., Prechl J., Nikolova M., Baleva M., Erdei A., Vassilev T. An antibody-based construct carrying DNA-mimotope and targeting CR1 (CD35) selectively suppresses human autoreactive B lymphocytes. Immunol. Lett. 2008, 116:168-173.
36. Wagner C., Ochmann C., Schoels M., Giese T., Stegmaier S., Richter R., Hug F., Hänsch G.M. The complement receptor 1, CR1 (CD35), mediates inhibitory signals in human T-lymphocytes. Mol. Immunol. 2006, 43:643-651.
37. Wan H., Winton H.L., Soeller C., Tovey E.R., Gruenert D.C., Thompson P.J., Stewart G.A., Taylor G.W., Garrod D.R., Cannell M.B., Robinson C. Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J. Clin. Invest. 1999, 104:123-133.
38. Yang X., Gieni R.S., Mosmann T.R., HayGlass K.T. Chemically modified antigen preferentially elicits induction of Th1-like cytokine synthesis patterns in vivo. J. Exp. Med. 1993, 178:349-353.
39. Zock J., Heinrich J., Jarvis D., Verlato G., Norbäck D., Plana E., Sunyer J., Chinn S., Olivieri M., Soon A., Villani S., Ponzio M., Dahlman-Hoglund A., Svanes C., Luczynska C. Distribution and determinants of house dust mite allergens in Europe: the European Community Respiratory Health Survey II. J. Allergy Clin. Immunol. 2000, 6:682-690.